Latest Commercialization Strategy News

Page 3 of 21
Unith Ltd boosted its AI digital human platform with ISO/IEC 27001:2022 certification, launched new SDKs, and secured $2.75 million in fresh capital to fuel growth and commercial expansion.
Sophie Babbage
Sophie Babbage
30 July 2026
ReNerve Limited delivered its strongest sales quarter ever with $211,000 in revenue, boosted by new distribution deals in Asia-Pacific and a $5 million funding facility to underpin growth.
Ada Torres
Ada Torres
29 July 2026
InteliCare generated positive cash flow for the first time since listing in the June 2026 quarter, driven by accelerated deployments across aged care and retirement living sectors.
Ada Torres
Ada Torres
29 July 2026
Siren Gold's mining permit application for Sams Creek was declined, yet the company reports strong exploration progress at Queen Charlotte and Langdons projects, positioning for future drilling.
Maxwell Dee
Maxwell Dee
28 July 2026
InteliCare has expanded its agreement with Hardi Aged Care by adding 84 beds at Blacktown and initiating a phased Nurse Call system deployment across six facilities, lifting contract value by 13%.
Sophie Babbage
Sophie Babbage
28 July 2026
Proteomics International Laboratories has streamlined operations, secured a key US patent for its endometriosis test, and inked a three-year exclusive distribution deal with Healius for its Promarker diagnostics in Australia.
Ada Torres
Ada Torres
27 July 2026
CLINUVEL Pharmaceuticals is relocating its corporate headquarters to the United States and reducing its global workforce by up to 20%, realigning its operations to focus solely on the US pharmaceutical market and unlock greater capital access.
Ada Torres
Ada Torres
23 July 2026
Pacific Edge edges closer to Medicare reimbursement for its bladder cancer tests while its Asia Pacific operations show rising test volumes and improved margins, signaling a path toward profitability.
Ada Torres
Ada Torres
14 July 2026
State Gas Limited clears a year-long ATO review to access $4.1 million in R&D tax concessions, enabling debt repayment and bolstering cash reserves. Meanwhile, independent certification of 30.2 petajoules of 2P gas reserves at Rolleston West strengthens its development prospects.
Maxwell Dee
Maxwell Dee
13 July 2026
OncoSil Medical has completed key manufacturing validation cycles with Cyclotek, paving the way for scalable Australian production of its OncoSil™ device. With a $2.1 million capital investment, the company aims to boost margins and supply chain control ahead of commercial launch in late 2026.
Ada Torres
Ada Torres
13 July 2026
Dimerix will provide continued access to its investigational drug DMX-200 for eligible patients with focal segmental glomerular sclerosis after completing the pivotal ACTION3 Phase 3 trial, supporting ongoing treatment ahead of regulatory approval.
Ada Torres
Ada Torres
9 July 2026
Proteomics International has won a key US patent for its PromarkerEndo blood test, bolstering its commercial foothold in the world’s largest healthcare market. The patented technology offers a non-invasive, accurate diagnosis of endometriosis, a condition that currently takes years to detect.
Ada Torres
Ada Torres
8 July 2026

Browse the archive

Full archive